000 01812 a2200553 4500
005 20250516060045.0
264 0 _c20120420
008 201204s 0 0 eng d
022 _a1432-0843
024 7 _a10.1007/s00280-011-1741-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJung, Donald
245 0 0 _aPharmacokinetics of TH-302: a hypoxically activated prodrug of bromo-isophosphoramide mustard in mice, rats, dogs and monkeys.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_cMar 2012
300 _a643-54 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAnimals
650 0 4 _aDogs
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aFemale
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aHypoxia
_xmetabolism
650 0 4 _aInfusions, Intravenous
650 0 4 _aInjections, Intraperitoneal
650 0 4 _aInjections, Intravenous
650 0 4 _aMacaca fascicularis
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred Strains
650 0 4 _aMice, Nude
650 0 4 _aMolecular Structure
650 0 4 _aNitroimidazoles
_xadministration & dosage
650 0 4 _aPhosphoramide Mustards
_xadministration & dosage
650 0 4 _aPredictive Value of Tests
650 0 4 _aProdrugs
_xadministration & dosage
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aSpecies Specificity
650 0 4 _aTissue Distribution
700 1 _aLin, Lin
700 1 _aJiao, Hailong
700 1 _aCai, Xiaohong
700 1 _aDuan, Jian-Xin
700 1 _aMatteucci, M
773 0 _tCancer chemotherapy and pharmacology
_gvol. 69
_gno. 3
_gp. 643-54
856 4 0 _uhttps://doi.org/10.1007/s00280-011-1741-6
_zAvailable from publisher's website
999 _c21201312
_d21201312